Cargando…

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)

BACKGROUND: Fatigue, exertion intolerance and post-exertional malaise are among the most frequent symptoms of Post-COVID Syndrome (PCS), with a subset of patients fulfilling criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). As SARS-CoV-2 infects endothelial cells, causing end...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haffke, Milan, Freitag, Helma, Rudolf, Gordon, Seifert, Martina, Doehner, Wolfram, Scherbakov, Nadja, Hanitsch, Leif, Wittke, Kirsten, Bauer, Sandra, Konietschke, Frank, Paul, Friedemann, Bellmann-Strobl, Judith, Kedor, Claudia, Scheibenbogen, Carmen, Sotzny, Franziska
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938726/ https://www.ncbi.nlm.nih.gov/pubmed/35317812 http://dx.doi.org/10.1186/s12967-022-03346-2

Ejemplares similares

Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
por: Jäkel, Bianka, et al.
Publicado: (2021)

Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study
por: Scheibenbogen, Carmen, et al.
Publicado: (2021)

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro
por: Flaskamp, Lavinia, et al.
Publicado: (2022)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
por: Scheibenbogen, Carmen, et al.
Publicado: (2018)

Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
por: Legler, Franziska, et al.
Publicado: (2023)

Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Szklarski, Marvin, et al.
Publicado: (2021)

Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report
por: Stein, Elisa, et al.
Publicado: (2023)

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Freitag, Helma, et al.
Publicado: (2021)

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
por: Sotzny, Franziska, et al.
Publicado: (2022)

Fighting Post-COVID and ME/CFS – development of curative therapies
por: Scheibenbogen, Carmen, et al.
Publicado: (2023)

Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS
por: Kim, Laura, et al.
Publicado: (2023)

Evaluation of a Webinar to Increase Health Professionals’ Knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Froehlich, Laura, et al.
Publicado: (2023)

Sarcopenia in stroke—facts and numbers on muscle loss accounting for disability after stroke
por: Scherbakov, Nadja, et al.
Publicado: (2011)

Searching for a relevant definition of sarcopenia: results from the cross‐sectional EPIDOS study
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Cachexia as a common characteristic in multiple chronic disease
por: Scherbakov, Nadja, et al.
Publicado: (2019)

Do we need a reference standard for the muscle mass measurements?
por: Scherbakov, Nadja, et al.
Publicado: (2018)

Comment on: “Experimental ischaemic stroke induces transient cardiac athrophy” by Veltkamp et al.
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Comment on ‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al.
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Endothelial dysfunction in ME/CFS patients
por: Sandvik, Miriam Kristine, et al.
Publicado: (2023)

Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Wirth, Klaus J., et al.
Publicado: (2021)

Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
por: Barkhudaryan, Anush, et al.
Publicado: (2021)

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020)

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray
por: Loebel, Madlen, et al.
Publicado: (2017)

Ischemic stroke and heart failure: facts and numbers
por: Scherbakov, Nadja, et al.
Publicado: (2015)

The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE
por: Scheibenbogen, Carmen, et al.
Publicado: (2017)

Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset
por: Steiner, Sophie, et al.
Publicado: (2020)

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
por: König, Rahel S., et al.
Publicado: (2022)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Rasa, Santa, et al.
Publicado: (2018)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies
por: Malato, João, et al.
Publicado: (2021)

Sleep‐Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction
por: Scherbakov, Nadja, et al.
Publicado: (2017)

The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression data
por: Malato, João, et al.
Publicado: (2021)

312 Medication Responses in Chronic Fatigue Syndrome (CFS) and Non-CFS Subjects
por: Esteitie, Rania, et al.
Publicado: (2012)

The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome
por: Yang, Chin-An, et al.
Publicado: (2018)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
por: Tölle, Markus, et al.
Publicado: (2020)

Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study
por: Klumbies, Katharina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32p2kvqfsj9pr3av8evlc8nitj